Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lim

Showing results (1451-1460 of 1,673) with videos related to

Pageof 168
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motifDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutantsDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
ESMO Real World Data and Digital Oncology|April 9, 2026
Digital health technology in oncology: results from a survey by the ESMO Young Oncologists Committee and medical student alumniP Mandó, M Moutafi, E A Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2024
Invention of novel 3-aminopiperidin-2-ones as calcitonin gene-related peptide receptor antagonistsDonnette D Staas, Ian M Bell, Christopher S Burgey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2020
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLCEmina Torlakovic, Roula Albadine, Gilbert Bigras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive CancersSoo-Chin Lee, Noriko Shimasaki, Joline S J Lim, et al.
The New England Journal of Medicine|June 1, 2025
Structured Exercise after Adjuvant Chemotherapy for Colon CancerKerry S Courneya, Janette L Vardy, Christopher J O'Callaghan, et al.
Molecular Cancer Research : MCR|July 25, 2018
Autophagy Governs Protumorigenic Effects of Mitotic Slippage-induced SenescenceRekha Jakhar, Monique N H Luijten, Alex X F Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trialKelvin Kw Chan, Ryan Wk Chu, Matthew C Cheung, et al.
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Pageof 168

Showing results (1451-1460 of 1,673) with videos related to

Sort By:
Pageof 168
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motifDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutantsDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
ESMO Real World Data and Digital Oncology|April 9, 2026
Digital health technology in oncology: results from a survey by the ESMO Young Oncologists Committee and medical student alumniP Mandó, M Moutafi, E A Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2024
Invention of novel 3-aminopiperidin-2-ones as calcitonin gene-related peptide receptor antagonistsDonnette D Staas, Ian M Bell, Christopher S Burgey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2020
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLCEmina Torlakovic, Roula Albadine, Gilbert Bigras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive CancersSoo-Chin Lee, Noriko Shimasaki, Joline S J Lim, et al.
The New England Journal of Medicine|June 1, 2025
Structured Exercise after Adjuvant Chemotherapy for Colon CancerKerry S Courneya, Janette L Vardy, Christopher J O'Callaghan, et al.
Molecular Cancer Research : MCR|July 25, 2018
Autophagy Governs Protumorigenic Effects of Mitotic Slippage-induced SenescenceRekha Jakhar, Monique N H Luijten, Alex X F Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trialKelvin Kw Chan, Ryan Wk Chu, Matthew C Cheung, et al.
Nature Communications|March 28, 2020
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaLi Ren Kong, Nur Afiqah Binte Mohamed Salleh, Richard Weijie Ong, et al.
Pageof 168